When you work with Worldwide Clinical Trials, you work with a resource-dedicated, global oncology team that seamlessly integrates with you. We’ll meet you where you are, leveraging our commitment to quality and vast experience in oncology development to customize solutions to your program.
Therapeutic Experts
Countries, All Regions
From early phase conceptualization through commercialization, our teams have the expertise and solutions to advance your program. Whether you’re looking for support for your global Phase 3 trial, need a consultation on your study design, or want to transition your study, we can help.
We face the complexities of oncology drug development and the highly competitive landscape head-on. Our flexible and adaptable methodology allows us to implement complex study designs well and drive better outcomes across tumor types.
We give you and your trial our full attention every step of the way. Our scientific, strategic, and operation experts are resource-dedicated to oncology development and are accessible when you need us, and our senior leadership is available for additional support. We’re focused on providing you with the best solutions to advance your trial and get your treatment to patients faster.
Our teams are experienced in diverse treatment modalities and utilize a modality-specific, strategic, biomarker-driven approach. From targeted therapies and cell and gene therapies to radiopharmaceuticals, we tailor our strategies to the unique demands of each program, fully supporting our sponsors in their quest for breakthroughs.
Though we are global, our teams are local. We have dedicated teams across the world — including in APAC, MENA, and the EU — that are skilled at providing you with local regulatory expertise and support. With an understanding of local standards of care, knowledge of regulations across agencies, and established site relationships across the globe, we can provide truly global services with the local support you need.
When we work with sites, we aim to build real relationships that support better development. Our medical monitors and global project leads work closely with sites to provide the support they need to recruit and retain patients and collect quality data. And our project teams’ understanding of the therapies, the competitive landscape, and the patient journey means sites have like-minded support from a team well-versed in the program.
We’re focused on increasing access to investigational treatments and reaching patients beyond academic hubs. Our recruitment and retention strategies employ innovative methods to reach patients, and we leverage patient-centered strategies to reduce the burden on families and patients to participate. We also incorporate the patent voice into our trials and, when applicable, utilize patient-reported outcomes to drive better results.
EVP Global Clinical Development
Vice President, Therapeutic Area Lead, Oncology
Executive Director, Site Activation & Regulatory Therapeutic Lead, Oncology
Vice President, Project Management, Oncology
Executive Director, Project Management, Oncology
Executive Director, Therapeutic Strategy Lead, Oncology & Hematology
Executive Director, Therapeutic Strategy Lead, Oncology
On May 1st, Industry Standard Research (ISR) announced the 2024 Leadership Awards, recognizing Phase 2/3 CROs for comprehensive excellence across their capabilities, compatibility, expertise, quality, and reliability.
In 2023, Worldwide Clinical Trials was named Most Innovative Clinical Research Organization (CRO) by the Triangle Business Journal (TBJ). This awards program celebrates the achievements of individuals and companies making critical advancements in pharmaceuticals, biotech, ag tech, and beyond, in the Triangle region of North Carolina.
Worldwide Clinical Trials, Inc., (Worldwide) the industry’s leading global, midsize, full-service contract research organization (CRO), has been recognized for excellence and honored in five categories in the 2022 CRO Leadership Awards, based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Leader magazines. This marks the ninth consecutive year that Worldwide has been recognized as a high-performing CRO based on direct survey feedback from pharmaceutical and biotech professionals.
Over 80% of respondents agreed that midsize CROs provide a strong cultural fit while being able to pivot quickly based on changing customer needs.